Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
Marrone Bio Innovations, Inc is an agricultural inputs business based in the US. Marrone Bio Innovations shares (MBII) are listed on the NASDAQ and all prices are listed in US Dollars. Marrone Bio Innovations employs 133 staff and has a trailing 12-month revenue of around USD$37.4 million.
|Latest market close||USD$1.15|
|52-week range||USD$0.6101 - USD$1.5|
|50-day moving average||USD$1.1577|
|200-day moving average||USD$1.1673|
|Wall St. target price||USD$1.99|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.187|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||-0.86%|
|1 month (2020-11-06)||-3.36%|
|3 months (2020-09-04)||-4.96%|
|6 months (2020-06-05)||10.58%|
|1 year (2019-12-05)||1.15|
|2 years (2018-12-04)||-14.81%|
|3 years (2017-12-05)||17.35%|
|5 years (2015-12-04)||-34.29%|
|Revenue TTM||USD$37.4 million|
|Gross profit TTM||USD$16.1 million|
|Return on assets TTM||-12.52%|
|Return on equity TTM||-109.51%|
|Market capitalisation||USD$178.4 million|
TTM: trailing 12 months
There are currently 1.9 million Marrone Bio Innovations shares held short by investors – that's known as Marrone Bio Innovations's "short interest". This figure is 1.3% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Marrone Bio Innovations shares can be evaluated.
Marrone Bio Innovations's "short interest ratio" (SIR) is the quantity of Marrone Bio Innovations shares currently shorted divided by the average quantity of Marrone Bio Innovations shares traded daily (recently around 126531.87331536). Marrone Bio Innovations's SIR currently stands at 14.84. In other words for every 100,000 Marrone Bio Innovations shares traded daily on the market, roughly 14840 shares are currently held short.
However Marrone Bio Innovations's short interest can also be evaluated against the total number of Marrone Bio Innovations shares, or, against the total number of tradable Marrone Bio Innovations shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Marrone Bio Innovations's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Marrone Bio Innovations shares in existence, roughly 10 shares are currently held short) or 0.0371% of the tradable shares (for every 100,000 tradable Marrone Bio Innovations shares, roughly 37 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Marrone Bio Innovations.
Find out more about how you can short Marrone Bio Innovations stock.
We're not expecting Marrone Bio Innovations to pay a dividend over the next 12 months.
Over the last 12 months, Marrone Bio Innovations's shares have ranged in value from as little as $0.6101 up to $1.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Marrone Bio Innovations's is 0.3008. This would suggest that Marrone Bio Innovations's shares are less volatile than average (for this exchange).
Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Regalia, a plant extract-based fungicidal biopesticide for plant disease and plant health; Grandevo, a bioinsecticide for insect and mite control; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, and reducing adult reproduction and egg hatch, as well as controls soil borne insects. The company also provides Stargus, a biofungicide to control plant diseases, such as Sclerotinia white molds, gray mold/bunch rot, and downy mildews; and Haven, a plant health product that is applied to the leaves of plants to reduce sun stress. In addition, it offers Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies. Additionally, the company provides Pro Farm products for increasing plant health, yield and quality; and Jet-Ag and Jet-Oxide, peroxyacetic acid-based plant health product lines that stops molds and bacteria on plants and other surfaces. Marrone Bio Innovations, Inc. serves agricultural and water treatment markets. The company provides its products directly through sales force, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.
Everything we know about the Loha Co. IPO, plus information on how to buy in.
Everything we know about the Stem Inc IPO, plus information on how to buy in.
Everything we know about the View Inc IPO, plus information on how to buy in.
Everything we know about the Chime IPO, plus information on how to buy in.
Steps to owning and managing WPRT, with 24-hour and historical pricing before you buy.
Steps to owning and managing WBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing WLK, with 24-hour and historical pricing before you buy.
Steps to owning and managing WDC, with 24-hour and historical pricing before you buy.
Steps to owning and managing WAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing VSAT, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.